BIOMARKERS AND METHODS FOR DETECTING ALZHEIMER'S DISEASE
摘要
Methods for classifying a test sample as indicative of Alzheimer's disease use protein and peptide biomarkers that are differentially expressed in the cerebral spinal fluid (CSF) of subjects with Alzheimer's disease relative to age-matched controls. The methods also use protein and peptide signatures indicative of Alzheimer's disease. Microarrays and kits for detecting the protein and peptide biomarkers in CSF samples can be used to classify Alzheimer's disease state from test samples.
申请公布号
WO2011005893(A2)
申请公布日期
2011.01.13
申请号
WO2010US41257
申请日期
2010.07.07
申请人
ABBOTT LABORATORIES;DEVANARAYAN, VISWANATH;PATTERSON, MELANIE, JOY;WARING, JEFFREY, F.;WITTE, DAVID
发明人
DEVANARAYAN, VISWANATH;PATTERSON, MELANIE, JOY;WARING, JEFFREY, F.;WITTE, DAVID